STAT

FEBRUARY 15, 2024

STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices.

Drug Pricing 257

Drug Pricing 257

European Pharmaceutical Review

JUNE 27, 2023

Regulatory challenges for microbiome-based therapeutics Microbiome-based therapies are new modalities, and each European national competent authority decides whether it should be regulated as a drug “or something else”. Conversely, in the US, it has always been clear and regulated as a drug.

Immunity 94

Immunity Immunization Chemotherapy Vaccines 94

Proxsys Rx

APRIL 19, 2024

And that is why the one 340B prediction we can make for 2024, unequivocally, is repeated three times in this post’s headline. Which means we may see a lot more states putting manufacturers in their place, in 2024. It’s a mystery to us. How covered entities should prepare for 340B changes in 2024 Build a qualified 340B team.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Packaging 52

Proxsys Rx

JANUARY 12, 2024

And that is why the one 340B prediction we can make for 2024, unequivocally, is repeated three times in this post’s headline. Which means we may see a lot more states putting manufacturers in their place, in 2024. It’s a mystery to us. How covered entities should prepare for 340B changes in 2024 Build a qualified 340B team.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Packaging 52